AmerisourceBergen Rep Previews the Year Ahead for Biosimilars: What’s Coming Down the Pipeline in 2022?

\n\n\n\nCfB: I’m Tony Hagen with The Center for Biosimilars. Today, we’re speaking with Sean McGowan. He’s the senior director of Biosimilars for AmerisourceBergen. Welcome, Sean.\n\n\n\nMcGowan: Hi, Tony. Thanks for having me.\n\n\n\nCfB: Sean, can you comment about biosimilar approvals in 2021? It was a pretty interesting year, I think, even though we had just a few.\n\n\n\nMcGowan: Yeah, it was it was quite a year of firsts for biosimilars in 2021.

Read the source article at Center for Biosimilars®
2022-01-24 19:00:00